The research concluded that automated notification of actionable TPADs did shorten the follow-up time by physicians for patients within their healthcare network. However, the researchers noted that future research is needed to evaluate such safety concerns as “The high proportion of actionable TPADs without any documented follow-up (~ 40%).”

Citation for the Full-text Article

Dalal AK, Schaffer A, Gershanik EF,Papanna R, Eibensteiner K, Nolido NV, Yoon CS, Williams D, Lipsitz SR, Roy CL, Schnipper JL. The impact of automated notification on follow-up of actionable tests pending at discharge: a cluster-randomized controlled trial. July 2018, 33(7):1043–1051. DOI: 10.1007/s11606-018-4393-y

Latest News from CRICO

Get all your medmal and patient safety news here.
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm